Welcome to our dedicated page for Phreesia news (Ticker: PHR), a resource for investors and traders seeking the latest updates and insights on Phreesia stock.
Phreesia, Inc. (NYSE: PHR) is a healthcare technology company focused on patient activation, digital intake, outreach and education for healthcare providers, life sciences companies and other organizations. The Phreesia news feed on Stock Titan highlights company announcements, financial updates and product developments that shape how it engages patients and supports healthcare workflows.
Investors and industry followers can use this page to review earnings releases and outlook updates, where Phreesia reports quarterly revenue, subscription and related services, payment processing fees, network solutions revenue and key metrics such as average healthcare services clients and revenue per client. These updates often include management commentary on operating leverage, cash flows and non-GAAP measures like Adjusted EBITDA.
The news stream also features transaction and financing disclosures, including details about the acquisition of AccessOne Parent Holdings, Inc., a provider of financing solutions for healthcare receivables, and related bridge loan and credit facility arrangements. These items are relevant for understanding Phreesia’s growth strategy and capital structure.
In addition, readers will find product and innovation news, such as the launch of Phreesia VoiceAI, an AI-driven phone solution for managing patient calls, and partnership and recognition stories, including the collaboration with Sesame Workshop and inclusion in rankings like the Deloitte Technology Fast 500™ and Capterra Shortlists. Bookmark this page to follow how Phreesia communicates its performance, platform enhancements and strategic initiatives over time.
Phreesia has been recognized by Becker’s Healthcare as one of the 150 Top Places to Work in Healthcare for 2022. This accolade highlights the company’s commitment to diversity, employee engagement, and professional growth. CEO Chaim Indig expressed pride in the recognition, emphasizing the company's supportive culture and opportunities for development. Phreesia's internal engagement platform, “Life@Phreesia,” focuses on wellness and community involvement, underlining the company's dedication to fostering a positive work environment.
Phreesia has been recognized as one of the 2022 Best Places to Work in Healthcare by Modern Healthcare for the sixth time. CEO Chaim Indig expressed pride in this accolade, highlighting the dedication of its remote workforce to improving healthcare experiences. This recognition reflects employee feedback, encompassing evaluations on culture, leadership, and benefits. The award honors organizations that prioritize support for their staff amidst challenges in the healthcare sector.
Phreesia announces Danielle Lynch's recognition as one of the 2022 PM360 ELITE 100 for her influential role in healthcare marketing. Honored in the Sales MVPs category, Lynch has significantly contributed to the company's growth since its IPO in 2019, helping to double the size of the Client Experience team and achieve a remarkable 77% revenue expansion during fiscal year 2022. Her innovative team-building approach fosters a collaborative culture, enhancing client partnerships and driving success.
Phreesia (NYSE: PHR) announced it will release its fiscal Q1 2023 financial results on June 2, 2022, after market close. A press release and a quarterly stakeholder letter will accompany the results and be available on its investor website. Following the release, the company will hold a conference call at 5:00 PM ET to discuss these results. Phreesia provides healthcare organizations with a SaaS platform for patient intake management, aimed at improving patient engagement and clinical efficiency.
Phreesia has announced that Danielle Lynch, Vice President of Client Experience, is recognized among the 'Women to Watch' by MM+M. This accolade honors influential leaders in healthcare marketing, with Lynch being one of only 25 selected for 2022.
Since Phreesia's IPO in 2019, Lynch has doubled her team and contributed to a nearly 100% increase in Life Sciences revenue, showcasing her innovation and leadership. David Linetsky praised her for building the Client Experience team that drives Phreesia Life Sciences' growth.
Phreesia, Inc. (NYSE: PHR) reported financial results for Q4 and FY 2022, emphasizing a strong revenue growth of 39% year-over-year to $58.0 million in Q4, and 43% growth to $213.2 million for the fiscal year. Despite increased revenues, Adjusted EBITDA was negative $30.5 million for Q4 and negative $59.0 million for the full year. Cash reserves stood at $313.8 million. Looking ahead, the company forecasts FY 2023 revenue between $271 million and $275 million, indicating a growth of 27% to 29%, but expects Adjusted EBITDA to worsen before recovering in FY 2025.
Phreesia, Inc. (NYSE: PHR) will host a conference call on March 30, 2022, at 5:00 p.m. ET to discuss its fiscal fourth quarter 2022 financial results. A press release detailing these results will be issued before the call, following market close on the same day. The company provides a suite of applications to enhance patient intake processes through its innovative SaaS platform, improving patient engagement and clinical care efficiency.
Phreesia (NYSE: PHR) has been named the 2022 Best in KLAS for Patient Intake Management for the fourth consecutive year, highlighting its excellence in healthcare IT services. The award, based on feedback from healthcare providers, recognizes Phreesia's robust platform that automates patient outreach and intake processes, including self-service registration and insurance verification. Phreesia earned a top score of 90.0, demonstrating its commitment to enhance clinical care and efficiency. CEO Chaim Indig emphasized ongoing investment in their platform to support healthcare providers.
Summary not available.
Phreesia has joined MEDITECH Greenfield, a pilot program aimed at fostering app integration with MEDITECH Expanse. This collaboration will enhance patient engagement in their care by enabling API-based integration, notifying patients about preventive care gaps, and reducing barriers to access. CEO Chaim Indig emphasized the importance of interoperability in healthcare, stating this partnership will support the development of innovative solutions for MEDITECH clients. The initiative aims to set an industry standard for interoperability.
FAQ
What is the current stock price of Phreesia (PHR)?
What is the market cap of Phreesia (PHR)?
